Pooled Analysis of the Phase 3 REVIVE Trials
With the growing numbers of bacterial infections becoming antibiotic-resistant, how do we treat and prevent recurrence of acute bacterial skin and skin structure infections (ASSI)? These infections can be extremely dangerous, causing abscesses, lesions, or ulcers that require surgical intervention.
This article compares two potential antibiotic remedies to ASSI: Iclaprim and Vancomycin.
Download the published article now to learn about the pooled analysis used in the 3 REVIVE trials, and whether the results show that one of the antibiotics could be a viable remedy for ASSI.
downloadExplore Our Key Related Services
Please fill out this form to access your resource.